No products in the cart.
Ciprofol 50?mg /?20?mL ×?5 vials – Wholesale price comparison Research Use Only
$1.00
Ciprofol (HSK3486), branded as Haisco®, is a next-generation, short?acting IV anesthetic and sedative—approximately 4–6?times more potent than propofol—with a favorable safety profile, including reduced injection pain and improved hemodynamic stability. Supplied as 50?mg in 20?mL sterile emulsion vials (5?×?20?mL), this product is strictly for laboratory and preclinical research. Not approved for clinical, diagnostic, therapeutic, or veterinary use.
Description
Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Ciprofol Injection (Haisco®) |
| Generic Name | Ciprofol (R?2?(1?cyclopropylethyl)?6?isopropylphenol) |
| CAS Number | 1637741?58?2 en.wikipedia.org+12en.wikipedia.org+12pmc.ncbi.nlm.nih.gov+12 |
| Molecular Formula | C??H??O |
| Molecular Weight | ~212 g/mol (approximate for formula) |
| Dosage Form | Sterile oil?in?water emulsion for IV injection |
| Strength | 50?mg per 20?mL vial (10?mg/mL) |
| Pack Size | 5 vials per box |
| Approval Number | China NMPA H20200013 |
| Product Code | 86906155000394 |
| Manufacturer | Liaoning Haisco Pharmaceutical Co., Ltd. |
| Storage Conditions | Store at 2–25?°C; shield from light; shake well before use |
| Intended Use | Laboratory and preclinical research only |
Mechanism of Action
Ciprofol acts as a selective GABAA_A receptor agonist, enhancing inhibitory neurotransmission. It binds more strongly than propofol, giving it 4–6× higher potency.
Research Applications & Pharmacology
Anesthesia & Sedation Models: Used in induction and maintenance protocols—with typical bolus doses of 0.2–0.5?mg/kg—demonstrating efficacy non-inferior to propofol in various clinical settings.
Preclinical Neuropharmacology: Ideal for mechanistic studies on sedation, analgesia, hemodynamics, and cardiac protection .
Comparative Efficacy: RCTs in GI endoscopy and gynecological procedures found similar sedation success to propofol but with reduced adverse events and injection pain.
Pharmacokinetics: Rapid onset (~1–2?min), short duration, primarily metabolized via liver glucuronidation, renal excretion .
Safety Profile & Handling
Adverse Events: Lower incidence of injection site pain and hypotension compared to propofol.
Handling: Use aseptic technique; single-use vial; discard unused portion per protocols; inspect emulsion before use.
Contraindications & Precautions: Potent sedation; monitor respiratory and cardiovascular status closely in vivo studies.
Storage: Maintain 2–25?°C, away from light. Emulsion remains stable under recommended conditions.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 18 × 16 × 18 cm |
Related products
Levobupivacaine Hydrochloride 37.5?mg ×?5 Vials Wholesale price comparison
Levobupivacaine is the S?enantiomer of bupivacaine, a long?acting amide?type local anesthetic offering reduced cardiotoxicity and prolonged nerve blockade. Each 5?mL vial contains 37.5?mg. Produced by Yichang Renfu Pharmaceutical Co., Ltd., approved under NMPA H20193347, product code 86902000002308, barcode 6930829980983.
?? For laboratory research use only.?Please consult the staff for other purposes? $1.00Lappaconitine Hydrobromide 4?mg ×?2 Ampoules Wholesale price comparison
Lappaconitine hydrobromide is a naturally derived diterpenoid alkaloid from Aconitum species, known for analgesic, anti-inflammatory, anti-arrhythmic, and antitumor effects. Each box contains two 2?mL ampoules at 4?mg each. Produced by Shandong Dongfangming Pharmaceutical Group Co., Ltd., NMPA approval number H20045497, product code 86904083001063, barcode 6935030530552.
?? For laboratory research use only.?Please consult the staff for other purposes?
CAS number: 97792?45?5 $3.00Propofol 20?mg/mL MCT/LCT Emulsion Injection 20?mL ×?5 Vials
This propofol formulation uses a medium-chain and long-chain triglyceride (MCT/LCT) emulsion, designed to produce equivalent anesthetic effects compared to long-chain-only emulsions while reducing injection pain and minimizing triglyceride accumulation. Each 20?mL vial contains 400?mg propofol (20?mg/mL).
?? For laboratory research use only?Please consult staff for other specifications and uses? $1.00Dexmedetomidine Hydrochloride Injection 0.2?mg/2?mL ×?5 Vials (Lyophilized Powder) [For Laboratory Research Use Only]
Dexmedetomidine hydrochloride is a highly selective ???adrenergic receptor agonist used in preclinical sedation and analgesia research. Each set includes five lyophilized vials of 0.2?mg dexmedetomidine in a 2?mL formulation. Produced by Sinopharm Group Langfang Co., Ltd., approved under NMPA H20203335 (product code: 86902581000113).
?? For laboratory research use only.?Please consult the staff for other purposes? $1.00
Reviews
There are no reviews yet.